CAS: 668270-11-9 - 1H-Purine-2,6-dione,8-[(3S)-3-amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-

Formel: C₂₅H₂₈N₈O₂

(S)-8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione (Linagliptin Impurity)

CAS: 668270-11-9

• Reinheit: 97%
• Farbe und Form: Solid
• Molekulargewicht: 472.553

(S)-Linagliptin

CAS: 668270-11-9

• Formel: C₂₅H₂₈N₈O₂
• Reinheit: 95%
• Farbe und Form: Solid
• Molekulargewicht: 472.5422

(S)-Linagliptin

CAS: 668270-11-9

• Formel: C₂₅H₂₈N₈O₂
• Farbe und Form: Pale Yellow Solid
• Molekulargewicht: 472.55

(S)-Linagliptin

CAS: 668270-11-9

Applications (S)-Linagliptin is a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use …

• Formel: C₂₅H₂₈N₈O₂
• Farbe und Form: Neat
• Molekulargewicht: 472.54

Linagliptin impurity G

CAS: 668270-11-9

Linagliptin impurity G is an impurity in the drug product Linagliptin. It is a natural …

• Formel: C₂₅H₂₈N₈O₂
• Reinheit: Min. 95%
• Molekulargewicht: 472.54 g/mol

Linagliptin Enantiomer

CAS: 668270-11-9

Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, …

• Formel: C₂₅H₂₈N₈O₂
• Molekulargewicht: 472.23352